Although the mechanisms of BDNF loss-induced neurogenesis dysfunction are still unclear, it has been reported that low levels of BDNF in the serum were associated with cognitive impairment in patients with cancer and animal models (Jehn et al., 2015; Zimmer et al., 2015). The gene discussed is BDNF; the disease is cancer.